Preservative-free hyaluronic acid (Hylabak (®)) for a range of patients with dry eye syndrome

Use of preservative-free hyaluronic acid (Hylabak (^®)) for a range of patients with dry eye syndrome: experience in Russia.

Article specifications

This review study was published in 2014 in Journal of Clin Ophthalmol. (IF 2014:2.00) by Russian specialists. All studies had an open, noncomparative design, but one compared the findings with those from 25 patients treated with Tear Naturale(^®) in previous studies. A total of 134 children and adults were enrolled, and the etiologies of dry eye syndrome included contact lens use, intensive office work, adenovirus eye infection, postmenopausal status, persistent meibomian blepharitis, Sjögren's syndrome, phacoemulsification with intraocular lens implantation, and refractive surgery. The patients were treated with Hylabak for 2 weeks to 2 months.

 

Results

In conclusion, Hylabak provided rapid and safe relief from the signs and symptoms of dry eye syndrome, as well as improvement in objective measures, in a wide range of patients.